nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—CYP2C9—Disulfiram—alcohol dependence	0.136	1	CbGbCtD
Epoprostenol—P2RY12—forebrain—alcohol dependence	0.00821	0.0545	CbGeAlD
Epoprostenol—PTGIS—cardiovascular system—alcohol dependence	0.00771	0.0512	CbGeAlD
Epoprostenol—PTGER1—pancreas—alcohol dependence	0.00697	0.0462	CbGeAlD
Epoprostenol—P2RY12—cardiovascular system—alcohol dependence	0.00694	0.0461	CbGeAlD
Epoprostenol—P2RY12—blood—alcohol dependence	0.00549	0.0364	CbGeAlD
Epoprostenol—PTGIR—brainstem—alcohol dependence	0.00543	0.036	CbGeAlD
Epoprostenol—PTGIS—endocrine gland—alcohol dependence	0.00529	0.0351	CbGeAlD
Epoprostenol—PTGIR—forebrain—alcohol dependence	0.00524	0.0348	CbGeAlD
Epoprostenol—PTGIS—testis—alcohol dependence	0.00504	0.0335	CbGeAlD
Epoprostenol—PTGIS—nervous system—alcohol dependence	0.00495	0.0329	CbGeAlD
Epoprostenol—PTGER1—endocrine gland—alcohol dependence	0.00492	0.0326	CbGeAlD
Epoprostenol—PTGIS—liver—alcohol dependence	0.00477	0.0316	CbGeAlD
Epoprostenol—PTGIS—central nervous system—alcohol dependence	0.00477	0.0316	CbGeAlD
Epoprostenol—P2RY12—endocrine gland—alcohol dependence	0.00476	0.0316	CbGeAlD
Epoprostenol—PTGER1—nervous system—alcohol dependence	0.0046	0.0305	CbGeAlD
Epoprostenol—P2RY12—nervous system—alcohol dependence	0.00446	0.0296	CbGeAlD
Epoprostenol—PTGER1—central nervous system—alcohol dependence	0.00443	0.0294	CbGeAlD
Epoprostenol—PTGIR—cardiovascular system—alcohol dependence	0.00443	0.0294	CbGeAlD
Epoprostenol—PTGIR—pancreas—alcohol dependence	0.00431	0.0286	CbGeAlD
Epoprostenol—P2RY12—central nervous system—alcohol dependence	0.00429	0.0285	CbGeAlD
Epoprostenol—PTGIR—gonad—alcohol dependence	0.00402	0.0267	CbGeAlD
Epoprostenol—PTGIS—brain—alcohol dependence	0.00378	0.0251	CbGeAlD
Epoprostenol—PTGIR—digestive system—alcohol dependence	0.00368	0.0244	CbGeAlD
Epoprostenol—PTGIR—blood—alcohol dependence	0.0035	0.0232	CbGeAlD
Epoprostenol—P2RY12—brain—alcohol dependence	0.00341	0.0226	CbGeAlD
Epoprostenol—PTGIR—endocrine gland—alcohol dependence	0.00304	0.0202	CbGeAlD
Epoprostenol—PTGIR—testis—alcohol dependence	0.0029	0.0192	CbGeAlD
Epoprostenol—PTGIR—nervous system—alcohol dependence	0.00284	0.0189	CbGeAlD
Epoprostenol—PTGIR—liver—alcohol dependence	0.00274	0.0182	CbGeAlD
Epoprostenol—PTGIR—central nervous system—alcohol dependence	0.00274	0.0182	CbGeAlD
Epoprostenol—PTGIR—cerebellum—alcohol dependence	0.00268	0.0178	CbGeAlD
Epoprostenol—PTGIR—brain—alcohol dependence	0.00217	0.0144	CbGeAlD
Epoprostenol—Chest discomfort—Citalopram—alcohol dependence	0.00199	0.00472	CcSEcCtD
Epoprostenol—Rectal haemorrhage—Citalopram—alcohol dependence	0.00195	0.00462	CcSEcCtD
Epoprostenol—Orthostatic hypotension—Acamprosate—alcohol dependence	0.00194	0.00462	CcSEcCtD
Epoprostenol—Cellulitis—Citalopram—alcohol dependence	0.00193	0.00459	CcSEcCtD
Epoprostenol—Paraesthesia—Disulfiram—alcohol dependence	0.00191	0.00453	CcSEcCtD
Epoprostenol—Somnolence—Disulfiram—alcohol dependence	0.00189	0.00449	CcSEcCtD
Epoprostenol—Gastritis—Acamprosate—alcohol dependence	0.00188	0.00448	CcSEcCtD
Epoprostenol—Abdominal distension—Acamprosate—alcohol dependence	0.00185	0.0044	CcSEcCtD
Epoprostenol—Fatigue—Disulfiram—alcohol dependence	0.00183	0.00435	CcSEcCtD
Epoprostenol—Pain—Disulfiram—alcohol dependence	0.00182	0.00432	CcSEcCtD
Epoprostenol—Neck pain—Citalopram—alcohol dependence	0.00178	0.00423	CcSEcCtD
Epoprostenol—Musculoskeletal pain—Citalopram—alcohol dependence	0.00178	0.00423	CcSEcCtD
Epoprostenol—Pulmonary embolism—Citalopram—alcohol dependence	0.00176	0.00418	CcSEcCtD
Epoprostenol—Influenza like illness—Citalopram—alcohol dependence	0.00171	0.00406	CcSEcCtD
Epoprostenol—Abdominal discomfort—Naltrexone—alcohol dependence	0.00167	0.00396	CcSEcCtD
Epoprostenol—Weight decreased—Acamprosate—alcohol dependence	0.00166	0.00395	CcSEcCtD
Epoprostenol—Pneumonia—Acamprosate—alcohol dependence	0.00165	0.00392	CcSEcCtD
Epoprostenol—Depression—Acamprosate—alcohol dependence	0.00163	0.00389	CcSEcCtD
Epoprostenol—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00162	0.00384	CcSEcCtD
Epoprostenol—Cramps of lower extremities—Citalopram—alcohol dependence	0.00161	0.00384	CcSEcCtD
Epoprostenol—Myocardial infarction—Acamprosate—alcohol dependence	0.00161	0.00382	CcSEcCtD
Epoprostenol—Urinary tract infection—Acamprosate—alcohol dependence	0.00159	0.00379	CcSEcCtD
Epoprostenol—CYP2C9—cardiovascular system—alcohol dependence	0.00158	0.0105	CbGeAlD
Epoprostenol—Weight decreased—Naltrexone—alcohol dependence	0.00157	0.00374	CcSEcCtD
Epoprostenol—Sweating—Acamprosate—alcohol dependence	0.00157	0.00374	CcSEcCtD
Epoprostenol—Haematuria—Acamprosate—alcohol dependence	0.00156	0.00372	CcSEcCtD
Epoprostenol—Pneumonia—Naltrexone—alcohol dependence	0.00156	0.00371	CcSEcCtD
Epoprostenol—Infestation NOS—Naltrexone—alcohol dependence	0.00155	0.00369	CcSEcCtD
Epoprostenol—Infestation—Naltrexone—alcohol dependence	0.00155	0.00369	CcSEcCtD
Epoprostenol—Depression—Naltrexone—alcohol dependence	0.00155	0.00368	CcSEcCtD
Epoprostenol—Epistaxis—Acamprosate—alcohol dependence	0.00155	0.00368	CcSEcCtD
Epoprostenol—Hyperkinesia—Citalopram—alcohol dependence	0.00153	0.00364	CcSEcCtD
Epoprostenol—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00153	0.00364	CcSEcCtD
Epoprostenol—Sepsis—Citalopram—alcohol dependence	0.00152	0.00362	CcSEcCtD
Epoprostenol—Asthenia—Disulfiram—alcohol dependence	0.00152	0.00362	CcSEcCtD
Epoprostenol—Myocardial infarction—Naltrexone—alcohol dependence	0.00152	0.00361	CcSEcCtD
Epoprostenol—Urinary tract infection—Naltrexone—alcohol dependence	0.00151	0.00358	CcSEcCtD
Epoprostenol—Haemoglobin—Acamprosate—alcohol dependence	0.00148	0.00352	CcSEcCtD
Epoprostenol—Rhinitis—Acamprosate—alcohol dependence	0.00148	0.00351	CcSEcCtD
Epoprostenol—Haemorrhage—Acamprosate—alcohol dependence	0.00147	0.0035	CcSEcCtD
Epoprostenol—Hypoaesthesia—Acamprosate—alcohol dependence	0.00146	0.00348	CcSEcCtD
Epoprostenol—Epistaxis—Naltrexone—alcohol dependence	0.00146	0.00348	CcSEcCtD
Epoprostenol—Pharyngitis—Acamprosate—alcohol dependence	0.00146	0.00347	CcSEcCtD
Epoprostenol—Sinusitis—Naltrexone—alcohol dependence	0.00146	0.00346	CcSEcCtD
Epoprostenol—Oedema peripheral—Acamprosate—alcohol dependence	0.00145	0.00345	CcSEcCtD
Epoprostenol—Eczema—Citalopram—alcohol dependence	0.00142	0.00337	CcSEcCtD
Epoprostenol—Hepatic failure—Citalopram—alcohol dependence	0.00142	0.00337	CcSEcCtD
Epoprostenol—Dizziness—Disulfiram—alcohol dependence	0.0014	0.00334	CcSEcCtD
Epoprostenol—Pharyngitis—Naltrexone—alcohol dependence	0.00138	0.00329	CcSEcCtD
Epoprostenol—Connective tissue disorder—Naltrexone—alcohol dependence	0.00137	0.00325	CcSEcCtD
Epoprostenol—Thirst—Citalopram—alcohol dependence	0.00134	0.00319	CcSEcCtD
Epoprostenol—Rash—Disulfiram—alcohol dependence	0.00134	0.00318	CcSEcCtD
Epoprostenol—Headache—Disulfiram—alcohol dependence	0.00133	0.00316	CcSEcCtD
Epoprostenol—Chills—Acamprosate—alcohol dependence	0.00132	0.00314	CcSEcCtD
Epoprostenol—CYP2C9—digestive system—alcohol dependence	0.00131	0.00872	CbGeAlD
Epoprostenol—Arthritis—Citalopram—alcohol dependence	0.00131	0.00312	CcSEcCtD
Epoprostenol—Cardiac failure—Citalopram—alcohol dependence	0.00131	0.00311	CcSEcCtD
Epoprostenol—Cardiac disorder—Naltrexone—alcohol dependence	0.00129	0.00307	CcSEcCtD
Epoprostenol—Mental disorder—Acamprosate—alcohol dependence	0.00129	0.00307	CcSEcCtD
Epoprostenol—Angiopathy—Naltrexone—alcohol dependence	0.00126	0.003	CcSEcCtD
Epoprostenol—Flatulence—Acamprosate—alcohol dependence	0.00126	0.003	CcSEcCtD
Epoprostenol—Tension—Acamprosate—alcohol dependence	0.00126	0.00299	CcSEcCtD
Epoprostenol—Mediastinal disorder—Naltrexone—alcohol dependence	0.00126	0.00298	CcSEcCtD
Epoprostenol—CYP2C9—blood—alcohol dependence	0.00125	0.00831	CbGeAlD
Epoprostenol—Chills—Naltrexone—alcohol dependence	0.00125	0.00297	CcSEcCtD
Epoprostenol—Nervousness—Acamprosate—alcohol dependence	0.00124	0.00296	CcSEcCtD
Epoprostenol—Back pain—Acamprosate—alcohol dependence	0.00124	0.00295	CcSEcCtD
Epoprostenol—Muscle spasms—Acamprosate—alcohol dependence	0.00123	0.00293	CcSEcCtD
Epoprostenol—Mental disorder—Naltrexone—alcohol dependence	0.00122	0.0029	CcSEcCtD
Epoprostenol—Tremor—Acamprosate—alcohol dependence	0.0012	0.00285	CcSEcCtD
Epoprostenol—Flatulence—Naltrexone—alcohol dependence	0.00119	0.00284	CcSEcCtD
Epoprostenol—Tension—Naltrexone—alcohol dependence	0.00119	0.00283	CcSEcCtD
Epoprostenol—Anaemia—Acamprosate—alcohol dependence	0.00118	0.00282	CcSEcCtD
Epoprostenol—Agitation—Acamprosate—alcohol dependence	0.00118	0.0028	CcSEcCtD
Epoprostenol—Nervousness—Naltrexone—alcohol dependence	0.00118	0.0028	CcSEcCtD
Epoprostenol—Back pain—Naltrexone—alcohol dependence	0.00117	0.00279	CcSEcCtD
Epoprostenol—Muscle spasms—Naltrexone—alcohol dependence	0.00117	0.00277	CcSEcCtD
Epoprostenol—Orthostatic hypotension—Citalopram—alcohol dependence	0.00116	0.00277	CcSEcCtD
Epoprostenol—Syncope—Acamprosate—alcohol dependence	0.00115	0.00273	CcSEcCtD
Epoprostenol—Tremor—Naltrexone—alcohol dependence	0.00114	0.0027	CcSEcCtD
Epoprostenol—Palpitations—Acamprosate—alcohol dependence	0.00113	0.00269	CcSEcCtD
Epoprostenol—Gastritis—Citalopram—alcohol dependence	0.00113	0.00268	CcSEcCtD
Epoprostenol—Loss of consciousness—Acamprosate—alcohol dependence	0.00113	0.00268	CcSEcCtD
Epoprostenol—Cough—Acamprosate—alcohol dependence	0.00112	0.00266	CcSEcCtD
Epoprostenol—Agitation—Naltrexone—alcohol dependence	0.00111	0.00265	CcSEcCtD
Epoprostenol—Abdominal distension—Citalopram—alcohol dependence	0.00111	0.00264	CcSEcCtD
Epoprostenol—Arthralgia—Acamprosate—alcohol dependence	0.00109	0.00259	CcSEcCtD
Epoprostenol—Chest pain—Acamprosate—alcohol dependence	0.00109	0.00259	CcSEcCtD
Epoprostenol—Myalgia—Acamprosate—alcohol dependence	0.00109	0.00259	CcSEcCtD
Epoprostenol—Syncope—Naltrexone—alcohol dependence	0.00109	0.00258	CcSEcCtD
Epoprostenol—Anxiety—Acamprosate—alcohol dependence	0.00109	0.00258	CcSEcCtD
Epoprostenol—CYP2C9—endocrine gland—alcohol dependence	0.00109	0.0072	CbGeAlD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00108	0.00258	CcSEcCtD
Epoprostenol—Palpitations—Naltrexone—alcohol dependence	0.00107	0.00255	CcSEcCtD
Epoprostenol—Dry mouth—Acamprosate—alcohol dependence	0.00107	0.00254	CcSEcCtD
Epoprostenol—Loss of consciousness—Naltrexone—alcohol dependence	0.00107	0.00253	CcSEcCtD
Epoprostenol—Cough—Naltrexone—alcohol dependence	0.00106	0.00251	CcSEcCtD
Epoprostenol—Abdominal discomfort—Citalopram—alcohol dependence	0.00106	0.00251	CcSEcCtD
Epoprostenol—Confusional state—Acamprosate—alcohol dependence	0.00105	0.00251	CcSEcCtD
Epoprostenol—Pancytopenia—Citalopram—alcohol dependence	0.00105	0.00249	CcSEcCtD
Epoprostenol—Anaphylactic shock—Acamprosate—alcohol dependence	0.00105	0.00249	CcSEcCtD
Epoprostenol—Infection—Acamprosate—alcohol dependence	0.00104	0.00247	CcSEcCtD
Epoprostenol—Arthralgia—Naltrexone—alcohol dependence	0.00103	0.00245	CcSEcCtD
Epoprostenol—Chest pain—Naltrexone—alcohol dependence	0.00103	0.00245	CcSEcCtD
Epoprostenol—Myalgia—Naltrexone—alcohol dependence	0.00103	0.00245	CcSEcCtD
Epoprostenol—Shock—Acamprosate—alcohol dependence	0.00103	0.00245	CcSEcCtD
Epoprostenol—Anxiety—Naltrexone—alcohol dependence	0.00103	0.00244	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00102	0.00244	CcSEcCtD
Epoprostenol—Thrombocytopenia—Acamprosate—alcohol dependence	0.00102	0.00243	CcSEcCtD
Epoprostenol—Tachycardia—Acamprosate—alcohol dependence	0.00102	0.00243	CcSEcCtD
Epoprostenol—Skin disorder—Acamprosate—alcohol dependence	0.00102	0.00241	CcSEcCtD
Epoprostenol—Hyperhidrosis—Acamprosate—alcohol dependence	0.00101	0.0024	CcSEcCtD
Epoprostenol—Dry mouth—Naltrexone—alcohol dependence	0.00101	0.0024	CcSEcCtD
Epoprostenol—Confusional state—Naltrexone—alcohol dependence	0.000998	0.00237	CcSEcCtD
Epoprostenol—Weight decreased—Citalopram—alcohol dependence	0.000997	0.00237	CcSEcCtD
Epoprostenol—Anorexia—Acamprosate—alcohol dependence	0.000997	0.00237	CcSEcCtD
Epoprostenol—Oedema—Naltrexone—alcohol dependence	0.000989	0.00235	CcSEcCtD
Epoprostenol—Anaphylactic shock—Naltrexone—alcohol dependence	0.000989	0.00235	CcSEcCtD
Epoprostenol—Pneumonia—Citalopram—alcohol dependence	0.000989	0.00235	CcSEcCtD
Epoprostenol—Infection—Naltrexone—alcohol dependence	0.000983	0.00234	CcSEcCtD
Epoprostenol—Infestation NOS—Citalopram—alcohol dependence	0.000983	0.00234	CcSEcCtD
Epoprostenol—Infestation—Citalopram—alcohol dependence	0.000983	0.00234	CcSEcCtD
Epoprostenol—Depression—Citalopram—alcohol dependence	0.00098	0.00233	CcSEcCtD
Epoprostenol—CYP2C9—liver—alcohol dependence	0.000979	0.00649	CbGeAlD
Epoprostenol—Hypotension—Acamprosate—alcohol dependence	0.000977	0.00232	CcSEcCtD
Epoprostenol—Shock—Naltrexone—alcohol dependence	0.000973	0.00231	CcSEcCtD
Epoprostenol—Nervous system disorder—Naltrexone—alcohol dependence	0.00097	0.00231	CcSEcCtD
Epoprostenol—Acute coronary syndrome—Citalopram—alcohol dependence	0.000969	0.0023	CcSEcCtD
Epoprostenol—Tachycardia—Naltrexone—alcohol dependence	0.000966	0.0023	CcSEcCtD
Epoprostenol—Myocardial infarction—Citalopram—alcohol dependence	0.000963	0.00229	CcSEcCtD
Epoprostenol—Skin disorder—Naltrexone—alcohol dependence	0.000961	0.00228	CcSEcCtD
Epoprostenol—Hyperhidrosis—Naltrexone—alcohol dependence	0.000956	0.00227	CcSEcCtD
Epoprostenol—Urinary tract infection—Citalopram—alcohol dependence	0.000955	0.00227	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000953	0.00226	CcSEcCtD
Epoprostenol—Insomnia—Acamprosate—alcohol dependence	0.000946	0.00225	CcSEcCtD
Epoprostenol—Anorexia—Naltrexone—alcohol dependence	0.000943	0.00224	CcSEcCtD
Epoprostenol—Sweating—Citalopram—alcohol dependence	0.000942	0.00224	CcSEcCtD
Epoprostenol—Paraesthesia—Acamprosate—alcohol dependence	0.000939	0.00223	CcSEcCtD
Epoprostenol—Haematuria—Citalopram—alcohol dependence	0.000937	0.00223	CcSEcCtD
Epoprostenol—Dyspnoea—Acamprosate—alcohol dependence	0.000932	0.00222	CcSEcCtD
Epoprostenol—Somnolence—Acamprosate—alcohol dependence	0.00093	0.00221	CcSEcCtD
Epoprostenol—Epistaxis—Citalopram—alcohol dependence	0.000927	0.0022	CcSEcCtD
Epoprostenol—Sinusitis—Citalopram—alcohol dependence	0.000922	0.00219	CcSEcCtD
Epoprostenol—Dyspepsia—Acamprosate—alcohol dependence	0.00092	0.00219	CcSEcCtD
Epoprostenol—Decreased appetite—Acamprosate—alcohol dependence	0.000909	0.00216	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000903	0.00215	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000901	0.00214	CcSEcCtD
Epoprostenol—Bradycardia—Citalopram—alcohol dependence	0.000898	0.00214	CcSEcCtD
Epoprostenol—Insomnia—Naltrexone—alcohol dependence	0.000895	0.00213	CcSEcCtD
Epoprostenol—Pain—Acamprosate—alcohol dependence	0.000894	0.00213	CcSEcCtD
Epoprostenol—Constipation—Acamprosate—alcohol dependence	0.000894	0.00213	CcSEcCtD
Epoprostenol—Paraesthesia—Naltrexone—alcohol dependence	0.000888	0.00211	CcSEcCtD
Epoprostenol—Haemoglobin—Citalopram—alcohol dependence	0.000887	0.00211	CcSEcCtD
Epoprostenol—Rhinitis—Citalopram—alcohol dependence	0.000885	0.0021	CcSEcCtD
Epoprostenol—Haemorrhage—Citalopram—alcohol dependence	0.000882	0.0021	CcSEcCtD
Epoprostenol—Dyspnoea—Naltrexone—alcohol dependence	0.000882	0.0021	CcSEcCtD
Epoprostenol—Somnolence—Naltrexone—alcohol dependence	0.00088	0.00209	CcSEcCtD
Epoprostenol—Hypoaesthesia—Citalopram—alcohol dependence	0.000878	0.00209	CcSEcCtD
Epoprostenol—Pharyngitis—Citalopram—alcohol dependence	0.000876	0.00208	CcSEcCtD
Epoprostenol—Oedema peripheral—Citalopram—alcohol dependence	0.000869	0.00207	CcSEcCtD
Epoprostenol—Connective tissue disorder—Citalopram—alcohol dependence	0.000867	0.00206	CcSEcCtD
Epoprostenol—Decreased appetite—Naltrexone—alcohol dependence	0.00086	0.00204	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000855	0.00203	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000854	0.00203	CcSEcCtD
Epoprostenol—Fatigue—Naltrexone—alcohol dependence	0.000853	0.00203	CcSEcCtD
Epoprostenol—Pain—Naltrexone—alcohol dependence	0.000846	0.00201	CcSEcCtD
Epoprostenol—Constipation—Naltrexone—alcohol dependence	0.000846	0.00201	CcSEcCtD
Epoprostenol—Urticaria—Acamprosate—alcohol dependence	0.000831	0.00197	CcSEcCtD
Epoprostenol—Body temperature increased—Acamprosate—alcohol dependence	0.000827	0.00197	CcSEcCtD
Epoprostenol—Abdominal pain—Acamprosate—alcohol dependence	0.000827	0.00197	CcSEcCtD
Epoprostenol—Cardiac disorder—Citalopram—alcohol dependence	0.000819	0.00195	CcSEcCtD
Epoprostenol—Flushing—Citalopram—alcohol dependence	0.000819	0.00195	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000809	0.00192	CcSEcCtD
Epoprostenol—Angiopathy—Citalopram—alcohol dependence	0.000801	0.0019	CcSEcCtD
Epoprostenol—Mediastinal disorder—Citalopram—alcohol dependence	0.000795	0.00189	CcSEcCtD
Epoprostenol—Chills—Citalopram—alcohol dependence	0.000792	0.00188	CcSEcCtD
Epoprostenol—Urticaria—Naltrexone—alcohol dependence	0.000786	0.00187	CcSEcCtD
Epoprostenol—Abdominal pain—Naltrexone—alcohol dependence	0.000782	0.00186	CcSEcCtD
Epoprostenol—Body temperature increased—Naltrexone—alcohol dependence	0.000782	0.00186	CcSEcCtD
Epoprostenol—Mental disorder—Citalopram—alcohol dependence	0.000773	0.00184	CcSEcCtD
Epoprostenol—Hypersensitivity—Acamprosate—alcohol dependence	0.00077	0.00183	CcSEcCtD
Epoprostenol—Flatulence—Citalopram—alcohol dependence	0.000757	0.0018	CcSEcCtD
Epoprostenol—Tension—Citalopram—alcohol dependence	0.000754	0.00179	CcSEcCtD
Epoprostenol—Asthenia—Acamprosate—alcohol dependence	0.00075	0.00178	CcSEcCtD
Epoprostenol—Nervousness—Citalopram—alcohol dependence	0.000746	0.00177	CcSEcCtD
Epoprostenol—Back pain—Citalopram—alcohol dependence	0.000743	0.00177	CcSEcCtD
Epoprostenol—Pruritus—Acamprosate—alcohol dependence	0.00074	0.00176	CcSEcCtD
Epoprostenol—Muscle spasms—Citalopram—alcohol dependence	0.000738	0.00176	CcSEcCtD
Epoprostenol—Hypersensitivity—Naltrexone—alcohol dependence	0.000729	0.00173	CcSEcCtD
Epoprostenol—Tremor—Citalopram—alcohol dependence	0.00072	0.00171	CcSEcCtD
Epoprostenol—Diarrhoea—Acamprosate—alcohol dependence	0.000715	0.0017	CcSEcCtD
Epoprostenol—Anaemia—Citalopram—alcohol dependence	0.00071	0.00169	CcSEcCtD
Epoprostenol—Asthenia—Naltrexone—alcohol dependence	0.00071	0.00169	CcSEcCtD
Epoprostenol—Agitation—Citalopram—alcohol dependence	0.000706	0.00168	CcSEcCtD
Epoprostenol—Pruritus—Naltrexone—alcohol dependence	0.0007	0.00166	CcSEcCtD
Epoprostenol—Dizziness—Acamprosate—alcohol dependence	0.000692	0.00164	CcSEcCtD
Epoprostenol—Syncope—Citalopram—alcohol dependence	0.000689	0.00164	CcSEcCtD
Epoprostenol—Palpitations—Citalopram—alcohol dependence	0.000679	0.00161	CcSEcCtD
Epoprostenol—Diarrhoea—Naltrexone—alcohol dependence	0.000677	0.00161	CcSEcCtD
Epoprostenol—Loss of consciousness—Citalopram—alcohol dependence	0.000675	0.0016	CcSEcCtD
Epoprostenol—Cough—Citalopram—alcohol dependence	0.00067	0.00159	CcSEcCtD
Epoprostenol—Vomiting—Acamprosate—alcohol dependence	0.000665	0.00158	CcSEcCtD
Epoprostenol—Rash—Acamprosate—alcohol dependence	0.000659	0.00157	CcSEcCtD
Epoprostenol—Dermatitis—Acamprosate—alcohol dependence	0.000659	0.00157	CcSEcCtD
Epoprostenol—Headache—Acamprosate—alcohol dependence	0.000655	0.00156	CcSEcCtD
Epoprostenol—Dizziness—Naltrexone—alcohol dependence	0.000654	0.00156	CcSEcCtD
Epoprostenol—Arthralgia—Citalopram—alcohol dependence	0.000654	0.00155	CcSEcCtD
Epoprostenol—Myalgia—Citalopram—alcohol dependence	0.000654	0.00155	CcSEcCtD
Epoprostenol—Chest pain—Citalopram—alcohol dependence	0.000654	0.00155	CcSEcCtD
Epoprostenol—Anxiety—Citalopram—alcohol dependence	0.000652	0.00155	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000649	0.00154	CcSEcCtD
Epoprostenol—Dry mouth—Citalopram—alcohol dependence	0.00064	0.00152	CcSEcCtD
Epoprostenol—Confusional state—Citalopram—alcohol dependence	0.000632	0.0015	CcSEcCtD
Epoprostenol—Vomiting—Naltrexone—alcohol dependence	0.000629	0.0015	CcSEcCtD
Epoprostenol—Oedema—Citalopram—alcohol dependence	0.000627	0.00149	CcSEcCtD
Epoprostenol—Anaphylactic shock—Citalopram—alcohol dependence	0.000627	0.00149	CcSEcCtD
Epoprostenol—Rash—Naltrexone—alcohol dependence	0.000624	0.00148	CcSEcCtD
Epoprostenol—Dermatitis—Naltrexone—alcohol dependence	0.000623	0.00148	CcSEcCtD
Epoprostenol—Infection—Citalopram—alcohol dependence	0.000623	0.00148	CcSEcCtD
Epoprostenol—Nausea—Acamprosate—alcohol dependence	0.000621	0.00148	CcSEcCtD
Epoprostenol—Headache—Naltrexone—alcohol dependence	0.00062	0.00147	CcSEcCtD
Epoprostenol—Shock—Citalopram—alcohol dependence	0.000617	0.00147	CcSEcCtD
Epoprostenol—Nervous system disorder—Citalopram—alcohol dependence	0.000615	0.00146	CcSEcCtD
Epoprostenol—Thrombocytopenia—Citalopram—alcohol dependence	0.000614	0.00146	CcSEcCtD
Epoprostenol—Tachycardia—Citalopram—alcohol dependence	0.000612	0.00145	CcSEcCtD
Epoprostenol—Skin disorder—Citalopram—alcohol dependence	0.000609	0.00145	CcSEcCtD
Epoprostenol—Hyperhidrosis—Citalopram—alcohol dependence	0.000606	0.00144	CcSEcCtD
Epoprostenol—Anorexia—Citalopram—alcohol dependence	0.000598	0.00142	CcSEcCtD
Epoprostenol—Nausea—Naltrexone—alcohol dependence	0.000588	0.0014	CcSEcCtD
Epoprostenol—Hypotension—Citalopram—alcohol dependence	0.000586	0.00139	CcSEcCtD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.00058	0.00198	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.00058	0.00198	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.00058	0.00198	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.00058	0.00198	CbGpPWpGaD
Epoprostenol—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000571	0.00136	CcSEcCtD
Epoprostenol—Insomnia—Citalopram—alcohol dependence	0.000567	0.00135	CcSEcCtD
Epoprostenol—Paraesthesia—Citalopram—alcohol dependence	0.000563	0.00134	CcSEcCtD
Epoprostenol—PTGER1—GPCR ligand binding—NPY—alcohol dependence	0.000562	0.00192	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—NPY—alcohol dependence	0.000562	0.00192	CbGpPWpGaD
Epoprostenol—Dyspnoea—Citalopram—alcohol dependence	0.000559	0.00133	CcSEcCtD
Epoprostenol—Somnolence—Citalopram—alcohol dependence	0.000557	0.00132	CcSEcCtD
Epoprostenol—Dyspepsia—Citalopram—alcohol dependence	0.000552	0.00131	CcSEcCtD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.000549	0.00187	CbGpPWpGaD
Epoprostenol—Decreased appetite—Citalopram—alcohol dependence	0.000545	0.0013	CcSEcCtD
Epoprostenol—PTGIS—Metabolism—ADH4—alcohol dependence	0.000544	0.00186	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HTR1B—alcohol dependence	0.000542	0.00185	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—HTR1B—alcohol dependence	0.000542	0.00185	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CRH—alcohol dependence	0.000542	0.00185	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CRH—alcohol dependence	0.000542	0.00185	CbGpPWpGaD
Epoprostenol—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000541	0.00129	CcSEcCtD
Epoprostenol—Fatigue—Citalopram—alcohol dependence	0.00054	0.00128	CcSEcCtD
Epoprostenol—Constipation—Citalopram—alcohol dependence	0.000536	0.00127	CcSEcCtD
Epoprostenol—Pain—Citalopram—alcohol dependence	0.000536	0.00127	CcSEcCtD
Epoprostenol—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000533	0.00182	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000531	0.00181	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000515	0.00176	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—DRD4—alcohol dependence	0.000515	0.00176	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000514	0.00176	CbGpPWpGaD
Epoprostenol—Gastrointestinal pain—Citalopram—alcohol dependence	0.000513	0.00122	CcSEcCtD
Epoprostenol—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000508	0.00174	CbGpPWpGaD
Epoprostenol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000501	0.00171	CbGpPWpGaD
Epoprostenol—Urticaria—Citalopram—alcohol dependence	0.000498	0.00118	CcSEcCtD
Epoprostenol—Body temperature increased—Citalopram—alcohol dependence	0.000496	0.00118	CcSEcCtD
Epoprostenol—Abdominal pain—Citalopram—alcohol dependence	0.000496	0.00118	CcSEcCtD
Epoprostenol—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000495	0.00169	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CNR1—alcohol dependence	0.000492	0.00168	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000488	0.00167	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000488	0.00167	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—OPRD1—alcohol dependence	0.000488	0.00167	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—DRD2—alcohol dependence	0.00048	0.00164	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—HTR7—alcohol dependence	0.00048	0.00164	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000474	0.00162	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000474	0.00162	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—DRD4—alcohol dependence	0.000474	0.00162	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—DRD4—alcohol dependence	0.000474	0.00162	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000471	0.00161	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—PDYN—alcohol dependence	0.000467	0.0016	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ADH7—alcohol dependence	0.000463	0.00158	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Citalopram—alcohol dependence	0.000462	0.0011	CcSEcCtD
Epoprostenol—PTGIR—GPCR ligand binding—CNR1—alcohol dependence	0.000453	0.00155	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CNR1—alcohol dependence	0.000453	0.00155	CbGpPWpGaD
Epoprostenol—Asthenia—Citalopram—alcohol dependence	0.00045	0.00107	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—OPRD1—alcohol dependence	0.000449	0.00153	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—OPRD1—alcohol dependence	0.000449	0.00153	CbGpPWpGaD
Epoprostenol—Pruritus—Citalopram—alcohol dependence	0.000444	0.00105	CcSEcCtD
Epoprostenol—PTGIS—Metabolism—GGT2—alcohol dependence	0.000444	0.00152	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—POMC—alcohol dependence	0.000443	0.00151	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—OPRD1—alcohol dependence	0.000443	0.00151	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HTR7—alcohol dependence	0.000442	0.00151	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—DRD2—alcohol dependence	0.000442	0.00151	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—HTR7—alcohol dependence	0.000442	0.00151	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—DRD2—alcohol dependence	0.000442	0.00151	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000441	0.00151	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000437	0.00149	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CRHR1—alcohol dependence	0.000435	0.00148	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—PDYN—alcohol dependence	0.00043	0.00147	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—PDYN—alcohol dependence	0.00043	0.00147	CbGpPWpGaD
Epoprostenol—Diarrhoea—Citalopram—alcohol dependence	0.000429	0.00102	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—PDYN—alcohol dependence	0.000425	0.00145	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000419	0.00143	CbGpPWpGaD
Epoprostenol—Dizziness—Citalopram—alcohol dependence	0.000415	0.000985	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—CHRM2—alcohol dependence	0.000409	0.0014	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—OPRD1—alcohol dependence	0.000408	0.00139	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—OPRD1—alcohol dependence	0.000408	0.00139	CbGpPWpGaD
Epoprostenol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000406	0.00139	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000406	0.00139	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000406	0.00139	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ADH1B—alcohol dependence	0.000406	0.00139	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—AVP—alcohol dependence	0.000404	0.00138	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CRHR1—alcohol dependence	0.0004	0.00137	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CRHR1—alcohol dependence	0.0004	0.00137	CbGpPWpGaD
Epoprostenol—Vomiting—Citalopram—alcohol dependence	0.000399	0.000947	CcSEcCtD
Epoprostenol—Rash—Citalopram—alcohol dependence	0.000395	0.00094	CcSEcCtD
Epoprostenol—Dermatitis—Citalopram—alcohol dependence	0.000395	0.000939	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—CRHR1—alcohol dependence	0.000395	0.00135	CbGpPWpGaD
Epoprostenol—Headache—Citalopram—alcohol dependence	0.000393	0.000934	CcSEcCtD
Epoprostenol—PTGIR—Signaling by GPCR—PDYN—alcohol dependence	0.000391	0.00133	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PDYN—alcohol dependence	0.000391	0.00133	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—OPRK1—alcohol dependence	0.000389	0.00133	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000383	0.00131	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CHRM2—alcohol dependence	0.000376	0.00128	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CHRM2—alcohol dependence	0.000376	0.00128	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—OPRM1—alcohol dependence	0.000375	0.00128	CbGpPWpGaD
Epoprostenol—Nausea—Citalopram—alcohol dependence	0.000372	0.000885	CcSEcCtD
Epoprostenol—PTGIR—GPCR ligand binding—AVP—alcohol dependence	0.000372	0.00127	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—AVP—alcohol dependence	0.000372	0.00127	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CHRM2—alcohol dependence	0.000371	0.00127	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CRHR1—alcohol dependence	0.000363	0.00124	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CRHR1—alcohol dependence	0.000363	0.00124	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—OPRK1—alcohol dependence	0.000358	0.00122	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—OPRK1—alcohol dependence	0.000358	0.00122	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000353	0.0012	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—OPRM1—alcohol dependence	0.000345	0.00118	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—OPRM1—alcohol dependence	0.000345	0.00118	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—NPY—alcohol dependence	0.000345	0.00118	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CHRM2—alcohol dependence	0.000341	0.00117	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CHRM2—alcohol dependence	0.000341	0.00117	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—OPRM1—alcohol dependence	0.000341	0.00116	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—HTR2A—alcohol dependence	0.000336	0.00115	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—MAOB—alcohol dependence	0.000336	0.00115	CbGpPWpGaD
Epoprostenol—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000334	0.00114	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CRH—alcohol dependence	0.000333	0.00114	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—HTR1B—alcohol dependence	0.000333	0.00114	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000324	0.00111	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000324	0.00111	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—NPY—alcohol dependence	0.000318	0.00109	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—NPY—alcohol dependence	0.000318	0.00109	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000318	0.00109	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—NPY—alcohol dependence	0.000314	0.00107	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—OPRM1—alcohol dependence	0.000314	0.00107	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—OPRM1—alcohol dependence	0.000314	0.00107	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—HTR2A—alcohol dependence	0.000309	0.00106	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HTR2A—alcohol dependence	0.000309	0.00106	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—HTR1B—alcohol dependence	0.000307	0.00105	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—HTR1B—alcohol dependence	0.000307	0.00105	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CRH—alcohol dependence	0.000307	0.00105	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CRH—alcohol dependence	0.000307	0.00105	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CRH—alcohol dependence	0.000302	0.00103	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—HTR1B—alcohol dependence	0.000302	0.00103	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—DRD4—alcohol dependence	0.000291	0.000995	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—GOT2—alcohol dependence	0.00029	0.000991	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—NPY—alcohol dependence	0.000289	0.000986	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—NPY—alcohol dependence	0.000289	0.000986	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ALDH2—alcohol dependence	0.000286	0.000976	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HTR1B—alcohol dependence	0.000278	0.000951	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HTR1B—alcohol dependence	0.000278	0.000951	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CRH—alcohol dependence	0.000278	0.000951	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CRH—alcohol dependence	0.000278	0.000951	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CNR1—alcohol dependence	0.000278	0.00095	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000275	0.000939	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—HTR7—alcohol dependence	0.000271	0.000927	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—DRD2—alcohol dependence	0.000271	0.000927	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.00027	0.000923	CbGpPWpGaD
Epoprostenol—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000269	0.000917	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—POMC—alcohol dependence	0.000268	0.000917	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—DRD4—alcohol dependence	0.000268	0.000915	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—DRD4—alcohol dependence	0.000268	0.000915	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—DRD4—alcohol dependence	0.000264	0.000903	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—OPRD1—alcohol dependence	0.000262	0.000894	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CNR1—alcohol dependence	0.000256	0.000874	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CNR1—alcohol dependence	0.000256	0.000874	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CNR1—alcohol dependence	0.000252	0.000863	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PDYN—alcohol dependence	0.000251	0.000857	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—GOT1—alcohol dependence	0.00025	0.000856	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—DRD2—alcohol dependence	0.00025	0.000853	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—HTR7—alcohol dependence	0.00025	0.000853	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—HTR7—alcohol dependence	0.00025	0.000853	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—DRD2—alcohol dependence	0.00025	0.000853	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—POMC—alcohol dependence	0.000247	0.000844	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—POMC—alcohol dependence	0.000247	0.000844	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—DRD2—alcohol dependence	0.000246	0.000842	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—HTR7—alcohol dependence	0.000246	0.000842	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—DRD4—alcohol dependence	0.000243	0.000831	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—DRD4—alcohol dependence	0.000243	0.000831	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—GOT2—alcohol dependence	0.000243	0.00083	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—OPRD1—alcohol dependence	0.000241	0.000822	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—OPRD1—alcohol dependence	0.000241	0.000822	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—WASF2—alcohol dependence	0.000233	0.000797	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CRHR1—alcohol dependence	0.000233	0.000797	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CNR1—alcohol dependence	0.000232	0.000794	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CNR1—alcohol dependence	0.000232	0.000794	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PDYN—alcohol dependence	0.000231	0.000789	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PDYN—alcohol dependence	0.000231	0.000789	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CYP2E1—alcohol dependence	0.000228	0.000781	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—AVP—alcohol dependence	0.000228	0.00078	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—DRD2—alcohol dependence	0.000227	0.000774	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HTR7—alcohol dependence	0.000227	0.000774	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—DRD2—alcohol dependence	0.000227	0.000774	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HTR7—alcohol dependence	0.000227	0.000774	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—WASF1—alcohol dependence	0.000224	0.000764	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CHRM2—alcohol dependence	0.000219	0.000749	CbGpPWpGaD
Epoprostenol—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000218	0.000744	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000216	0.000738	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—WASF2—alcohol dependence	0.000215	0.000733	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—WASF2—alcohol dependence	0.000215	0.000733	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CRHR1—alcohol dependence	0.000215	0.000733	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CRHR1—alcohol dependence	0.000215	0.000733	CbGpPWpGaD
Epoprostenol—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000213	0.000727	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—AVP—alcohol dependence	0.00021	0.000718	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—AVP—alcohol dependence	0.00021	0.000718	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—GOT1—alcohol dependence	0.00021	0.000717	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—GGT1—alcohol dependence	0.00021	0.000717	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—AVP—alcohol dependence	0.000207	0.000708	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—WASF1—alcohol dependence	0.000206	0.000703	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—WASF1—alcohol dependence	0.000206	0.000703	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CHRM2—alcohol dependence	0.000202	0.000689	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CHRM2—alcohol dependence	0.000202	0.000689	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—OPRM1—alcohol dependence	0.000201	0.000688	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000198	0.000677	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—AVP—alcohol dependence	0.000191	0.000652	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—AVP—alcohol dependence	0.000191	0.000652	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—HTR2A—alcohol dependence	0.00019	0.000649	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—MAOA—alcohol dependence	0.000188	0.000642	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NPY—alcohol dependence	0.000185	0.000633	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—OPRM1—alcohol dependence	0.000185	0.000633	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—OPRM1—alcohol dependence	0.000185	0.000633	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000182	0.000623	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR1B—alcohol dependence	0.000179	0.000611	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CRH—alcohol dependence	0.000179	0.000611	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000178	0.000607	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—HTR2A—alcohol dependence	0.000175	0.000597	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—HTR2A—alcohol dependence	0.000175	0.000597	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—HTR2A—alcohol dependence	0.000173	0.000589	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NPY—alcohol dependence	0.00017	0.000582	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NPY—alcohol dependence	0.00017	0.000582	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CRH—alcohol dependence	0.000164	0.000562	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR1B—alcohol dependence	0.000164	0.000562	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR1B—alcohol dependence	0.000164	0.000562	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CRH—alcohol dependence	0.000164	0.000562	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—EP300—alcohol dependence	0.000159	0.000544	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HTR2A—alcohol dependence	0.000159	0.000542	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HTR2A—alcohol dependence	0.000159	0.000542	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—DRD4—alcohol dependence	0.000156	0.000534	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—POMC—alcohol dependence	0.000152	0.000518	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CNR1—alcohol dependence	0.000149	0.00051	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—EP300—alcohol dependence	0.000147	0.000501	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—DRD2—alcohol dependence	0.000146	0.000497	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR7—alcohol dependence	0.000146	0.000497	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—DRD4—alcohol dependence	0.000144	0.000491	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—DRD4—alcohol dependence	0.000144	0.000491	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—POMC—alcohol dependence	0.00014	0.000477	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—POMC—alcohol dependence	0.00014	0.000477	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—POMC—alcohol dependence	0.000138	0.000471	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CNR1—alcohol dependence	0.000137	0.000469	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CNR1—alcohol dependence	0.000137	0.000469	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—DRD2—alcohol dependence	0.000134	0.000458	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—DRD2—alcohol dependence	0.000134	0.000458	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR7—alcohol dependence	0.000134	0.000458	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR7—alcohol dependence	0.000134	0.000458	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—POMC—alcohol dependence	0.000127	0.000433	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—POMC—alcohol dependence	0.000127	0.000433	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADH6—alcohol dependence	0.000125	0.000426	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AVP—alcohol dependence	0.000122	0.000418	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—POMC—alcohol dependence	0.000122	0.000418	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—POMC—alcohol dependence	0.000116	0.000395	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AVP—alcohol dependence	0.000113	0.000385	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AVP—alcohol dependence	0.000113	0.000385	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADH1A—alcohol dependence	0.000103	0.000353	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR2A—alcohol dependence	0.000102	0.000348	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—EP300—alcohol dependence	9.69e-05	0.000331	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR2A—alcohol dependence	9.38e-05	0.00032	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR2A—alcohol dependence	9.38e-05	0.00032	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADH4—alcohol dependence	8.79e-05	0.0003	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—POMC—alcohol dependence	8.14e-05	0.000278	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—EP300—alcohol dependence	8.12e-05	0.000277	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	7.61e-05	0.00026	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—POMC—alcohol dependence	7.49e-05	0.000256	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—POMC—alcohol dependence	7.49e-05	0.000256	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADH7—alcohol dependence	7.48e-05	0.000255	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GGT2—alcohol dependence	7.17e-05	0.000245	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADH1B—alcohol dependence	6.55e-05	0.000224	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MAOB—alcohol dependence	5.43e-05	0.000186	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—EP300—alcohol dependence	5.4e-05	0.000184	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—EP300—alcohol dependence	4.97e-05	0.00017	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—EP300—alcohol dependence	4.97e-05	0.00017	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALDH2—alcohol dependence	4.62e-05	0.000158	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.44e-05	0.000152	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GOT2—alcohol dependence	3.93e-05	0.000134	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP2E1—alcohol dependence	3.69e-05	0.000126	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GGT1—alcohol dependence	3.39e-05	0.000116	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GOT1—alcohol dependence	3.39e-05	0.000116	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MAOA—alcohol dependence	3.04e-05	0.000104	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.95e-05	0.000101	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—POMC—alcohol dependence	1.98e-05	6.76e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—EP300—alcohol dependence	1.31e-05	4.48e-05	CbGpPWpGaD
